相关实验视频
Updated: Jun 17, 2025

07:44
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
324
在mRNA SARS-CoV-2免疫接种后发生急性广泛肺栓塞
Safi Ur Rehman Daim1, Aya Alsermani2, Renad Khalid Althomali2
1Mayo hospital, Anarkali, Lahore 54000, Punjab, Pakistan.
Radiology case reports
|August 6, 2024
概括
严重的血栓栓塞是COVID-19疫苗的罕见但严重的副作用. 这份病例报告详细介绍了一名年轻女性在接种瑞-BNT162b2 mRNA疫苗后发生的肺栓塞,强调及时诊断和管理.
科学领域:
- 免疫学 免疫学 免疫学
- 心脏病学 心脏病学
- 药物监督 药物监督 药物监督
背景情况:
- COVID-19疫苗对于疾病控制至关重要,通常具有轻微的副作用.
- 严重的不良事件,包括血栓塞栓症,很少发生,但在授权后进行监测.
- 病毒载体疫苗更频繁地与血栓栓塞事件有关.
研究的目的:
- 在没有风险因素的患者中报告Pfizer-BNT162b2 mRNA COVID-19疫苗后广泛的肺栓塞病例.
- 强调识别和管理不常见的疫苗相关不良事件的重要性.
主要方法:
- 一个26岁的女性在接种疫苗后出现肺栓塞的病例报告.
- 临床管理包括埃诺沙巴林和血栓抑制药物治疗 (Altaplase).
- 随访与血栓友爱查和长期抗凝药 (阿皮克萨班).
主要成果:
- 该患者在接种了瑞-BNT162b2 mRNA疫苗后发生了广泛的肺栓塞.
- 她没有先前存在的血栓栓塞瘤风险因素.
- 使用埃诺沙巴林,阿尔塔普拉兹,随后使用阿皮克萨班的治疗导致了血栓形成的临床改善和解决.
结论:
- 这一案例强调了与mRNA COVID-19疫苗相关的罕见但严重的不良事件的发生,例如肺栓塞.
- 持续的营销后监测对于识别和理解不常见的副作用至关重要.
- 及时诊断和管理对于患有疫苗相关血栓栓塞事件的患者的良好结果至关重要.
更多相关视频
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.7K
08:05Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
14.1K
相关概念视频
Pneumonia III: Complications and Assessment
193
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
193
Pneumonia I: Introduction
216
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
216